✦ LIBER ✦

Cardiovascular Risk in Kidney Transplant Recipients Receiving Mammalian Target of Rapamycin Inhibitors

✍ Scribed by E. Watorek; M. Szymczak; M. Boratynska; D. Patrzalek; M. Klinger

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Mammalian Target of Rapamycin Inhibitor

✍ B. L. Kasiske; A. de Mattos; S. M. Flechner; L. Gallon; H.-U. Meier-Kriesche; M. 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 475 KB

Clinical Outcomes in Kidney Transplant R

✍ F. Cortazar; M. Z. Molnar; T. Isakova; M. E. Czira; C. P. Kovesdy; D. Roth; I. M 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 560 KB

Reducing the Risk of Left Ventricular Hy

✍ E. Paoletti; G. Cannella 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 110 KB

Pneumonitis Associated With Mammalian Ta

✍ P. Errasti; D. Izquierdo; P. Martín; M. Errasti; F. Slon; A. Romero; F.J. Lavill 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 90 KB

Low-Dose Calcineurin Inhibitor Regimen C

✍ S. Kacar; A. Gurkan; C. Karaca; C. Varılsuha; S. Tilif 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 136 KB

Calcineurin inhibitor sparing regimens u

✍ Martin Zeier; Markus Van Der Giet 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 199 KB